0001574251-26-000001.txt : 20260702 0001574251-26-000001.hdr.sgml : 20260702 20260702120737 ACCESSION NUMBER: 0001574251-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260702 DATE AS OF CHANGE: 20260702 EFFECTIVENESS DATE: 20260702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mati Therapeutics Inc. CENTRAL INDEX KEY: 0001574251 ORGANIZATION NAME: EIN: 462000931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-558333 FILM NUMBER: 261149074 BUSINESS ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 329-6360 MAIL ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 D/A 1 primary_doc.xml X0708 D/A LIVE 0001574251 Mati Therapeutics Inc. 101 Colorado Street Suite 2409 AUSTIN TX TEXAS 78701 512-720-1333 DELAWARE 10152012, Inc. None Corporation true Robert Butchofsky 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Executive Officer Director Christopher Muller 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Executive Officer Director Joseph Tortorice III 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Director Cameron Nelson 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Executive Officer Peter McDonnell 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Director Ken Jones 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Director Jim Mazzo 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Director Dave Fellows 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Director Linda Lupini 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Director Biotechnology Decline to Disclose 06b true 0001574251-25-000002 2025-09-12 true true true Revenue Share false 0 4896500 2649815 2246685 false 2 0 0 0 false Mati Therapeutics Inc. Robert Butchofsky Robert Butchofsky Chief Executive Officer 2026-07-02